NCT04728698: A trial that was reported late by Sorrento Therapeutics, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04728698 |
|---|---|
| Title | Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 31, 2021 |
| Completion date | Sept. 30, 2021 |
| Required reporting date | Sept. 30, 2022, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 17, 2021 |
| Days late | None |